Arkolith/Insider Trading/OCX/Form 4

Arno Andrew

DirectorOncocyte Corp (OCX) · full profile →Form 4 · filed Aug 19, 2022
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2022Buy(P)8K$0.90$7K15K
Aug 17, 2022Buy(P)8K$0.90$7K15K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-023522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML